Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
59.49
-2.33 (-3.77%)
At close: Jul 20, 2026, 4:00 PM EDT
59.31
-0.18 (-0.30%)
After-hours: Jul 20, 2026, 7:58 PM EDT

Moderna Revenue

Moderna had revenue of $389.00M in the quarter ending March 31, 2026, with 260.19% growth. This brings the company's revenue in the last twelve months to $2.23B, down -29.97% year-over-year. In the year 2025, Moderna had annual revenue of $1.94B, down -39.93%.

Revenue (ttm)
$2.23B
Revenue Growth
-29.97%
P/S Ratio
10.61
Revenue / Employee
$473,404
Employees
4,700
Market Cap
23.60B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.94B-1.29B-39.93%
Dec 31, 20243.24B-3.61B-52.75%
Dec 31, 20236.85B-12.42B-64.45%
Dec 31, 202219.26B792.00M4.29%
Dec 31, 202118.47B17.67B2,200.25%
Dec 31, 2020803.00M743.00M1,238.33%
Dec 31, 201960.00M-75.07M-55.58%
Dec 31, 2018135.07M-70.76M-34.38%
Dec 31, 2017205.83M97.43M89.88%
Dec 31, 2016108.40M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition